Glenmark Life Sciences Q3 Results

  • BSE: 543322
  • NSE: GLS
  • ISIN: INE03Q201024
  • Sector: Biotechnology & Drugs
BSE
825.8-0.20 (-0.02%)
Volume5.33 K
Updated: Wed 29 May, 2024 | 15:28:02
NSE
826.2-0.05 (-0.01%)
Volume79.47 K
Updated: Wed 29 May, 2024 | 15:29:54
Today: 813.05
836.45
52-Wk: 526.55
904.20

Q3 Results Highlights

    Note: Comparison is on QoQ basis

    Quarterly - Glenmark Life Sciences Q3 Results

    *All figures in crores except per share values
    Fiscal PeriodDec 23Sep 23QoQ CompDec 22YoY Comp
    Total Revenue 2,134.021,882.7813.34%2,191.88-2.64%
    Selling/ General/ Admin Expenses Total 168.42161.744.13%151.2311.37%
    Depreciation/ Amortization 61.0361.74-1.15%61.21-0.29%
    Other Operating Expenses Total 60.9438.1959.60%47.9827.03%
    Total Operating Expense 1,687.451,477.4614.21%1,658.271.76%
    Operating Income 446.57405.3210.18%533.61-16.31%
    Net Income Before Taxes 316.31287.0910.18%433.83-27.09%
    Net Income 242.72217.1611.77%323.65-25.01%
    Diluted Normalized EPS 25.1022.4511.80%33.47-25.01%

    Recommended For You

      More Recommendations

      Trending Stocks

        Subscribe to Our Newsletter

        Get daily newsletters around different themes from livemint.

        Subscribe
        HomeMarketsPremiumFor youGet App